(Q38936876)

7 September 2017

title

Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010. (English)

1 reference

7 September 2017

0 references

0 references

8

Patrick L F Zuber

1 reference

7 September 2017

7

Mamoudou H Djingarey

1 reference

7 September 2017

Maman S Chaibou

1

1 reference

7 September 2017

Harouna Bako

2

1 reference

7 September 2017

Laouali Salisou

3

1 reference

7 September 2017

Téné M Yaméogo

4

1 reference

7 September 2017

Mariama Sambo

5

1 reference

7 September 2017

Sung Hye Kim

6

1 reference

7 September 2017

William A Perea

9

1 reference

7 September 2017

Lorenzo Pezzoli

10

1 reference

7 September 2017

language of work or name

English

0 references

publication date

16 June 2012

1 reference

7 September 2017

1 reference

7 September 2017

volume

30

1 reference

7 September 2017

issue

35

1 reference

7 September 2017

page(s)

5229-5234

1 reference

Manson Lecture. Meningococcal meningitis in Africa

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

The Meningitis Vaccine Project

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Product Development Partnerships Hit Their Stride: Lessons From Developing A Meningitis Vaccine For Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Eliminating epidemic Group A meningococcal meningitis in Africa through a new vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Whom and where are we not vaccinating? Coverage after the introduction of a new conjugate vaccine against group A meningococcus in Niger in 2010

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Adverse drug reactions: definitions, diagnosis, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Monitoring of adverse events during the 2003 mass vaccination campaign with a trivalent meningococcal A/C/W135 polysaccharide vaccine in Burkina Faso

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Guidelines for collection, analysis and presentation of vaccine safety data in pre- and post-licensure clinical studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Guidelines for collection, analysis and presentation of vaccine safety data in surveillance systems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Review of national spontaneous reporting schemes. Strengths and weaknesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Group C meningococcal polysaccharide-tetanus toxoid conjugate vaccine: a meta-analysis of immunogenicity, safety and posology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Health care seeking behavior for diarrhea in children under 5 in rural Niger: results of a cross-sectional survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Case-fatality rate during a measles outbreak in eastern Niger in 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Post-licensure safety of the meningococcal group C conjugate vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Epidemiological basis for clinical diagnosis of childhood malaria in endemic zone in West Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Subcutaneous versus intramuscular injection for booster DT vaccination of adolescents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Ensuring Injection Safety during Measles Immunization Campaigns: More than Auto‐Disable Syringes and Safety Boxes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

A vaccine against meningitis in Africa

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

The reporting sensitivities of two passive surveillance systems for vaccine adverse events

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Comparison of epidemiologic methods for active surveillance of vaccine safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

First, catch your signal!

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Statistical assessment of the association between vaccination and rare adverse events post-licensure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Population-based study of rotavirus vaccination and intussusception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

Immunization safety priority project at the World Health Organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

The Brighton Collaboration-enhancing vaccine safety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2012.06.006

10.1016/J.VACCINE.2012.06.006

7 January 2021

Identifiers

DOI

1 reference

7 September 2017

1 reference